Sign in to view content

Variability of Retinal Thickness in Diabetic macular edema (DME) Patients Treated with 0.19mg Fluocinolone Acetonide (FAc, ILUVIEN).

Christopher D. Riemann, MD

Video
Published 2019

Related

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Caroline Baumal, MD, FASRS
Annual Meeting Talks
2021
Early Treatment Patterns and Outcomes in Patients With Neovascular Age-Related Macular Degeneration Initiating Faricimab: The FARETINA-AMD Study
Theodore Leng, MD, MS, FASRS
Annual Meeting Talks
2023
Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019

Category: Diabetic Retinopathy

See more